ADVERSE-EFFECTS OF ALPHA-2B INTERFERON (IFN) IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC)
Citation
Fj. Giles et al., ADVERSE-EFFECTS OF ALPHA-2B INTERFERON (IFN) IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 184-184
Categorie Soggetti
Hematology
SICI code
0007-1048(1998)102:1<184:AOAI(I>2.0.ZU;2-B